Laurus Labs Reports Significant Profit Growth and Strong Financial Metrics Amid Market Evaluation
Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, recently experienced an evaluation adjustment due to its strong financial performance for the quarter ending March 2025. The company reported significant growth in net profit, high return on capital employed, and record net sales, indicating effective management and market positioning.
Laurus Labs, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment reflecting its strong market position and financial metrics. The company reported very positive financial performance for the quarter ending March 2025, showcasing a remarkable growth in net profit of 210.5%. This impressive result is complemented by a high return on capital employed (ROCE) of 18.50%, indicating effective management efficiency.In addition, Laurus Labs achieved its highest operating profit to interest ratio at 7.46 times, alongside record net sales of Rs 1,720.30 crore and a PBDIT of Rs 420.60 crore for the quarter. The stock's technical indicators have also shown a shift to a bullish range, supported by favorable trends in MACD, Bollinger Bands, and KST.
With a PEG ratio of 0.7 and high institutional holdings at 37.29%, Laurus Labs is positioned well compared to its peers, trading at a discount relative to historical valuations. Over the past year, the stock has generated a return of 36.85%, significantly outperforming the broader market.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
